These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 37821528)
1. A preliminary study on the mechanism of VASH2 in childhood medulloblastoma. Liu W; Fu Y; Wang M; Zhao J; Chen J; Wang Y; Qin H Sci Rep; 2023 Oct; 13(1):17153. PubMed ID: 37821528 [TBL] [Abstract][Full Text] [Related]
2. LOXL1-AS1 contributes to metastasis in sonic-hedgehog medulloblastoma by promoting cancer stem-like phenotypes. Do AD; Wu KS; Chu SS; Giang LH; Lin YL; Chang CC; Wong TT; Hsieh CL; Sung SY J Exp Clin Cancer Res; 2024 Apr; 43(1):130. PubMed ID: 38689348 [TBL] [Abstract][Full Text] [Related]
3. Functional analysis of HOXA10 and HOXB4 in human medulloblastoma cell lines. Bonfim-Silva R; Ferreira Melo FU; Thomé CH; Abraham KJ; De Souza FAL; Ramalho FS; Machado HR; De Oliveira RS; Cardoso AA; Covas DT; Fontes AM Int J Oncol; 2017 Dec; 51(6):1929-1940. PubMed ID: 29039487 [TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31. Chen Y; Shang H; Zhang S; Zhang X J Cell Biochem; 2018 Aug; 119(8):6527-6534. PubMed ID: 29377269 [TBL] [Abstract][Full Text] [Related]
5. Primary microcephaly gene CENPE is a novel biomarker and potential therapeutic target for non-WNT/non-SHH medulloblastoma. Fang H; Zhang Y; Lin C; Sun Z; Wen W; Sheng H; Lin J Front Immunol; 2023; 14():1227143. PubMed ID: 37593739 [TBL] [Abstract][Full Text] [Related]
6. Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk. D'Asti E; Kool M; Pfister SM; Rak J J Thromb Haemost; 2014 Nov; 12(11):1838-49. PubMed ID: 25163932 [TBL] [Abstract][Full Text] [Related]
7. CTGF expression is indicative of better survival rates in patients with medulloblastoma. Cruzeiro GAV; Lira RCP; de Almeida Magalhães T; Scrideli CA; Valera ET; Baumgartner M; Tone LG Cancer Gene Ther; 2020 May; 27(5):378-382. PubMed ID: 31073205 [TBL] [Abstract][Full Text] [Related]
8. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling. Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471 [TBL] [Abstract][Full Text] [Related]
9. RBM5 Acts as Tumor Suppressor in Medulloblastoma through Regulating Wnt/β-Catenin Signaling. Yu J; Ji G; Shi W; Zhao R; Shen W; Zheng J; Li H; Jiang F Eur Neurol; 2020; 83(3):242-250. PubMed ID: 32610314 [TBL] [Abstract][Full Text] [Related]
10. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis. Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167 [TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586 [TBL] [Abstract][Full Text] [Related]
12. [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition]. Wang J; Yu C; Jiang X; Wu X; Jia Y; Zhang H; Li Z Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):966-975. PubMed ID: 35869758 [TBL] [Abstract][Full Text] [Related]
13. Ligustrazine Inhibits Growth, Migration and Invasion of Medulloblastoma Daoy Cells by Up-Regulation of miR-211. Xu D; Chi G; Zhao C; Li D Cell Physiol Biochem; 2018; 49(5):2012-2021. PubMed ID: 30244244 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of GPR137 suppresses proliferation of medulloblastoma cells in vitro. Wang C; Liang Q; Chen G; Jing J; Wang S Biotechnol Appl Biochem; 2015; 62(6):868-73. PubMed ID: 25524330 [TBL] [Abstract][Full Text] [Related]
15. Uniformity under in vitro conditions: Changes in the phenotype of cancer cell lines derived from different medulloblastoma subgroups. Chlapek P; Zitterbart K; Kren L; Filipova L; Sterba J; Veselska R PLoS One; 2017; 12(2):e0172552. PubMed ID: 28231263 [TBL] [Abstract][Full Text] [Related]
16. Overexpressed TP73 induces apoptosis in medulloblastoma. Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635 [TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes. Korshunov A; Okonechnikov K; Schrimpf D; Tonn S; Mynarek M; Koster J; Sievers P; Milde T; Sahm F; Jones DTW; von Deimling A; Pfister SM; Kool M Acta Neuropathol; 2023 Jun; 145(6):829-842. PubMed ID: 37093271 [TBL] [Abstract][Full Text] [Related]
18. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry. Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267 [TBL] [Abstract][Full Text] [Related]
19. Combination of PARP and WEE1 inhibitors Lukoseviciute M; Theodosopoulou A; Holzhauser S; Dalianis T; Kostopoulou ON Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37144508 [TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy. Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]